Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

NCT00370214 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00370214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00370214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
Lead sponsor
Actelion
Phase
Observational
Overall status
Completed
Start date
March 31, 2006
Completion date
December 31, 2012
Enrollment
3,515 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension